07 Epidemiologi Kv

60
Community Medicine Department Faculty of Medicine University of Indonesia SETYAWATI BUDININGSIH, RETNO ASTI WERDHANI May 3rd. 2010

description

tes

Transcript of 07 Epidemiologi Kv

  • Community Medicine Department Faculty of Medicine University of Indonesia

    SETYAWATI BUDININGSIH, RETNO ASTI WERDHANI

    May 3rd. 2010

  • DESCRIPTIVE EPIDEMIOLOGY

    Incidence Prevalence

    Holistic Diagnosis (BIOPSYCHOSOSIAL)

    Risk Factors

    Diagnostic Tools

    ANALYTIC EPIDEMIOLOGY

    Therapy, Prognosis CLINICAL EPIDEMIOLOGY (Prognostic Study, Clinical Trial, Meta Analysis)

    Triad Epidemiology Host Agent - Environment

  • Cardiovascular disease is caused by disorders of the heart and blood vessels, and includes coronary heart disease (heart attacks), cerebrovascular disease (stroke), raised blood pressure (hypertension), peripheral artery disease, rheumatic heart disease, congenital heart disease and heart failure.

    The major causes of cardiovascular disease are tobacco use, physical inactivity, and an unhealthy diet.

  • Predispose factors : Age, Gender, Family history, Behavior,

    Sanitation, etc

    Clinical Risk factors : Obesity/Malnourished, Hypertension

    Dyslipidemia, Impairment of Glucose Control, and Systemic Inflammation, etc

  • Smoking raises risk of atherosclerotic disease and potentiates myocardial infarction (MI)

    Smoking cessation reduces the risk of MI and mortality by 36%

    Smoking cessation : education about the danger of smoking and intervention with nicotine replacement and bupropion

    Relapse rate are high in the absence of education and encouragement.

  • Hypertension Atherosclerotic Coronary Heart Disease and

    Peripheral Vascular Disease Congestive Heart Failure Congenital Heart Disease Valvular Health Disease Cardiac Arrhythmias

  • SKRT 2001 6 % HTN at 25-34 yr 15 % HTN at 35-44 yr 43 % HTN at > 55 yr 2/3 uncontrolled HTN patients at > 60 yr will have

    CHD, MCI, or Stroke within 5 year

    Risk of HTN is regulated by genetic background and environmental factors

    For every 20/10 mmHg increase BP above 115/75 mmHg, risk of CVD doubles (Chobanian et al, 2003)

  • Prevalensi hipertensi pada penduduk umur 18 tahun ke atas di Indonesia adalah sebesar 31.7 %

    Prevalensi stroke di Indonesia adalah 8.3 per 1000 penduduk

  • JAMA. 1990;263:1795-1801

  • The reduction of BP, reduces risk of acute cardiovascular events, progression of atherosclerosis, and end organ injury

    5 mmHg SBP reduction reduces 14 % stroke death and 9 % CVD death (Chobanian et al, 2003)

    2 mmHg DBP reduction has benefit for prevention (Cook NR, 1996)

  • Atherosclerosis begins in childhood and evolves over decades (Freedman et al, 1988), affecting > 85% adults > 50yr old (Tuzcu et al, 2001)

    Causes Coronary Artery Disease (CAD) and Peripheral Vascular Disease (PVD)

    Risk factors : Dyslipidemia, Hypertension, Impairment of Glucose Control, Age, family history, smoking, obesity, and systemic inflammation

  • High HDL level reduce the risk of developing CAD (Toth, 2001)

    Patients with familial low HDL have increase risk of premature CAD (Toth, 2003)

    Patients with familial high HDL are relatively resistant to CAD (Toth, 2004)

    The more elevated level of HDL, the lower the risk for CAD

  • Risk factors for CAD Negative : HDL > 60 mg/dl Positive : Cigarette smoking HDL < 40 mg/dl (men), < 50 mg/dl (women) BP > 140 / > 90 (or use of antihypertensive agents) Family history of premature CAD (CAD in male first

    degree relative < 55 yr; CAD in female first degree relative < 65yr)

    Age (men >=45 yr; women >=55 yr)

  • Risk Assessment Tool for Estimating 10-year Risk of Developing Hard Coronary Heart Disease (Myocardial Infarction and Coronary Death) The risk assessment tool below uses recent data from the Framingham Heart Study to estimate 10-year risk for hard coronary heart disease outcomes (myocardial infarction and coronary death). This tool is designed to estimate risk in adults aged 20 and older who do not have heart disease or diabetes. Use the calculator below to estimate 10-year risk.

    Age: years Gender: Female Male

    Total Cholesterol: mg/dL

    HDL Cholesterol: mg/dL Smoker: No Yes

    Systolic Blood Pressure: mm/Hg Currently on any medication to treat high blood pressure. No Yes

    35

    46

    190

    110

  • CVD Diabetes

    Hypertension

    Dyslipidemia Low HDL, high TG

    Hyperglycemia

    Hypercoagulability Impaired fibrinolysis

    Endothelial dysfunction

    Change in Adipose

    hormones

    Birth size, Childhood

    growth

    Hyperuricemia

    Systemic inflammation

    Socioeconomic status

    Physical Inactivity

    Genetic predisposition Diet

    Abdominal obesity, Ectopic fat deposition

    Insulin Resistance

    The Metabolic Syndrome

    Textbook of Family Medicine, Rakel, 07

  • The incidence of Metabolic Syndrome increases in men and women as a function of age (Ford et al 2002, Alexander et al 2003)

    Patients with Metabolic Syndrome had 3.77 fold increase in risk of CVD mortality compared to patients without it (Lakka et al 2002)

  • Patients who have ANY THREE (3) of five risk factors meet criteria for the metabolic syndrome

    Risk Factor Defining Level Abdominal obesity Men : Waist > 90 cm

    Women : Waist > 80 cm Triglycerides >=150 mg/dl HDL Men : < 40 mg/dl

    Women : < 50 mg/dl Blood Pressure >=130 / >=85 mmHg Fasting Glucose >=100 mg/dl

  • A clinical syndrome resulting from the inability of the heart to meet metabolic requirements of the body at normal filling measure

    Patient with CHF should have their CVD risk factors controlled aggressively

    Target BP for CHF patients

  • An illness of children and adolescents with the average age of onset 8-10 yr

    Associated with pharyngitis, caries dentis (bad oral hygiene), poverty, crowded living conditions, and difference in access to or utilization of medical care

  • Nepal : High rates of RHD may not relate to increased prevalence of streptococcal infection, but to inadequate antibiotic therapy (proper dosage and duration) of streptococcal pharyngitis.

    Philippines: giving penicillin to school children with pharyngitis (prior to confirmation of its etiology), can reduce the attack rate of rheumatic fever by ten folds.

  • Patients with established cardiac complications must be regularly followed-up.

    This requires cooperation and understanding of prognosis by patients and relatives and counseling on the doctors part

  • Ventricular Septal Defect Atrial Septal Defect Tetralogy Fallot Pulmonary Stenosis Patent Ductus Arteriosus Idiopathic Pulmonary Artery Dilatation Dextrocardia Hipertensi Pulmonal Primum. Lain-lain

  • Only 1% of the children with congenital heart disease are today properly treated in Indonesia.

    The lack of the information and education on the part of the patients

    Uneven distribution of doctors A shortage of pediatrician A shortage of funding, both privately and

    publicly Number of cardiac surgery hospital

  • **Resource: WHO and World Bank 2005

    CARDIOVASCULARDISEASES

    CANCER

    CHRONICRESPIRATORY

    DISEASE

    DIABETES

    17.528.000

    7.586.000

    4.057.000

    1.125.000

    MALARIA

    TUBERCULOSISHIV/AIDS

    2.830.000

  • WHO Statistics 2007

  • Age-standardized CVD mortality rate per 100.000 population (2002)

    0 100 200 300 400 500

    United States

    United Kingdom

    India

    Jepang

    Indonesia

    Filipina

    Vietnam

    Timor Leste

    CO

    UN

    TRIE

    S

    MORTALITY RATE

    mortality

    Thailand

    Singapore

    Malaysia

    China

    Srilanka

    Australia

    Canada

    WHO Statistics 2007

    441

    171 336

    274 361

    291 106

    314 428

    140 182

    141 188

    318 199

  • HOST : Characteristic :

    Age, Gender, Behavior,

    etc

    ENVIRONMENT : Family, Occupation,

    Housing, Sanitation, etc

    AGENT : Lipid, Glucose, Bacterial, etc

    DISEASE OCCURANCE : TRIAD EPIDEMIOLOGY

  • Pharmacology Drugs

    Non Pharmacology (health education/ counseling) on : Diet, Exercise, Smoking Cessation, Drugs compliance

  • Individual Perceptions

    Perceived susceptibility/

    Severity of disease

    Cues to action : Education,

    Symptom, illness Media Information

    Perceived threat of disease

    Age, gender, ethnicity, Personality,

    Socioeconomics, Knowledge

    Modifying Factors

    Likelihood of Behavior change

    Perceived benefits Minus perceived

    Barriers to behavior change

    Likelihood of Action

    Health Behavior and Health Education, Glanz et al, 1997

  • Promotion Prevention Surveillance and Early Treatment

    Social Determinants (Culture, Economy,

    Finance)

    Promotion and Prevention

  • A man, 58 years old, sees his family doctor because of chest pain. He had been well until 2 weeks ago, when he noticed tightness in the center of his chest when he was walking uphill.

    Remember Risk Factors (Biopsychosocial)

    58

    Died 60 of CVD

    Died ? of DM

  • Due to lots of contributing factors and broad-integrated disease management :

    Continuing care and monitoring are important to provide good health services for cardiovascular disease

    Educational approach and family participation are needed for : Patient to cope with the disease Getting patient and familys independence

    for improving/maintaining health status

  • Menanggulangi kemiskinan dan kelaparan Mencapai pendidikan dasar untuk semua Mendorong kesetaraan gender dan pemberdayaan

    perempuan Menurunkan angka kematian anak Meningkatkan kesehatan ibu Memerangi HIV/AIDS, malaria, dan penyakit

    menular lainnya Memastikan kelestarian lingkungan hidup

  • Riskesdas 2007 Profil Kesehatan Indonesia 2005 www. americanheart.org Toth PP, et al: Cardiovascular Disease. In: Rakel RE, et all (ed):

    Textbook of Family Medicine, 7th ed. Philadelphia, Saunders Elsevier, 2007:735-805

    Branch WT, et al (ed): Cardiology in Primary Care, Intl ed. New York, McGraw-Hill, 2000

    Fletcher RH, et al: Clinical Epidemiology the essentials, 2nd ed. Baltimore,Williams & Wilkins, 1988

    Glanz K, et al: Health Behavior and Health Education, 2nd ed. San Francisco, Jossey-Bass Publishers, 1997

    Affandi M. Penyakit Jantung Bawaan: Apa yang harus dilakukan?. Cermin Dunia Kedokteran no 31

    A Ibrahim, et all. Rheumatic Heart Disease: How Big is the Problem?. Med J Malaysia vol 50 no 2 June 1995

    Balaban DJ: Epidemiology and Prevention of Selected Chronic Illnesses. In: Cassens BJ (ed): Preventive Medicine and Public Health, 2nd ed. Philadelphia, Harwal Publishing,1992:135-138